↓ Skip to main content

Can a β-glucan-containing orthomolecular agent (Saccharomyces sp.) containing metabolic cofactors attenuate cytokine activation and alleviate hypoxia in COVID-19 patients?

Overview of attention for article published in International Journal of Clinical Pharmacology and Therapeutics, October 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#15 of 539)
  • High Attention Score compared to outputs of the same age (94th percentile)

Mentioned by

news
3 news outlets